DCGO241220P7000
- 0.00
- 0.000.00%
DocGo Newsroom
DocGo Announces Participation at Three Upcoming Investor Conferences
Do Its Financials Have Any Role To Play In Driving DocGo Inc.'s (NASDAQ:DCGO) Stock Up Recently?
Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and DocGo (DCGO)
Deutsche Bank Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $5
Needham Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $7
Analysts' Top Healthcare Picks: DocGo (DCGO), Resmed (RMD)
DocGo Inc. (DCGO) Tops Q3 Earnings Estimates
Express News | DocGo Inc FY2025 Rev View $705.3 Mln -- LSEG IBES Data
DocGo Reports Q3 EPS 5c, Consensus 5c
DocGo Sees FY24 Revenue $620M-$630M, Consensus $619.2M
10-Q: Q3 2024 Earnings Report
Earnings Flash (DCGO) DOCGO Posts Q3 Revenue $138.7M
Express News | DocGo Q3 Gross Margin 33%
Express News | DocGo Outlook FY Adjusted Ebitda USD 70-75 Million
Express News | DocGo Q3 Revenue USD 138.7 Million Vs. IBES Estimate USD 137.9 Million
Express News | DocGo Q3 Net Income USD 4.5 Million Vs. IBES Estimate USD 4.35 Million
Press Release: DocGo Announces Third Quarter 2024 Results
Earnings Preview: DocGo to Report Financial Results Post-market on November 07
DocGo to Announce Third Quarter 2024 Results on Thursday, November 7, 2024